Breathing is a vital and life-sustaining function supporting homeostatic processes, most critically maintaining blood pH/CO₂ and O₂ levels within a narrow physiological range. Respiratory homeostasis is mediated by neuron-modulated lung ventilation adjustments in response to physiological deviations resulting in high pCO₂ or low pO₂ blood and tissue levels, known as the hypercapnic and hypoxic reflexes, respectively (Del Negro et al., 2018; Dick et al., 2018). These reflexes are part of a complex brainstem neural network that integrates a multitude of information streams across the central and peripheral nervous systems to regulate respiratory output. Within this brainstem network, central noradrenergic (NA) neurons are known to be an important component that plays a variety of roles in modulating breathing. Furthermore, various perturbations across the central NA system have been implicated in several developmental disorders with respiratory and chemosensory features such as Congenital Central Hyperventilation Syndrome (CCHS), Sudden Infant Death Syndrome (SIDS), and Rett Syndrome (Beltrán-Castillo et al., 2017; Feldman et al., 2013; Gauda et al., 2007; Viemari, 2008). Thus, understanding how central NA neurons modulate respiratory chemoreflexes or chemosensory breathing is critically important for the development of new diagnostic and therapeutic interventions to address respiratory pathophysiology.

Central NA neurons are commonly thought to exert their effect on breathing through their primary neurotransmitter noradrenaline and adrenaline. However, in addition to noradrenaline, several studies provide strong evidence that glutamate is co-transmitted in subsets of central NA neurons. Vesicular glutamate transporter 2 (Vglut2), a gene marker of glutamatergic signaling, has been shown to be co-expressed in subsets of central NA neurons including, C1/A1, C2/A2, A5, and LC in adult rats and mice (DePuy et al., 2013; Souza et al., 2022a; Stornetta et al., 2002a; Stornetta et al., 2002b; Yang et al., 2021), though NA-specific expression of related Vglut1 and Vglut3 transporters remains unknown. Additionally, it has been well documented that central NA neurons co-expressing Vglut2 innervate key respiratory centers, such as preBötzinger complex and parafacial region (pFRG). Additionally, central NA neurons co-expressing Vglut2 project to many key autonomic brainstem, spinal cord, and forebrain centers, such as the dorsal motor nucleus of the vagus, intermediolateral nucleus and sympathetic system, and the hypothalamus, all of which could drive a change in breathing if perturbed, that is, indirect effects from cardiovascular and metabolic dysregulation (Supplementary file 1). Thus, it has become a dominant paradigm in the field of respiratory physiology that NA-based glutamate release is a critical form of neurotransmission in the control of breathing. Abbott et al., 2014 showed that Vglut2 is required for an increase in respiratory rate when anterior C1 neurons are unilaterally optogenetically stimulated. Malheiros-Lima et al., 2020 showed that Vglut2-expressing C1 neurons project to the pFRG region, and hypoxic breathing was blunted after blockade of ionotropic glutamatergic receptors at the pFRG site in anesthetized rats, together supporting a role for anterior C1 neurons releasing glutamate at the pFRG site to regulate breathing under hypoxia. Similarly, Malheiros-Lima et al., 2022 and Malheiros-Lima et al., 2018 showed that Vglut2-expressing C1 neurons project to the NA A5 region and the preBötzinger complex, and, again, the blockade of ionotropic glutamatergic receptors at the A5 region or preBötzinger complex reduced the increase in phrenic nerve activity and respiratory frequency elicited by optogenetic stimulation of C1 cells in an anesthetized preparation. In addition, Guyenet et al., 2013 and others speculated that the apparent lack of plasmalemmal monoamine transporter in C1 fibers indicates reduced or absent NA or adrenergic signaling due a lack of re-uptake and neurotransmitter pool depletion (Comer et al., 1998; Lorang et al., 1994). Cumulatively, the studies argue for glutamate as the predominant functional neurotransmitter for C1 NA neurons in the breathing neural network. To our knowledge, this dominant perspective has not been otherwise previously challenged. Although these studies are informative, the evidence supporting the role of NA-based Vglut2 signaling in respiratory control are either indirect and circumstantial or cannot be seen as physiological given experimental limitations, such as the focal nature of optogenetic stimulation. Thus, it is not yet clear what the requirement is for NA-based glutamatergic signaling in homeostatic breathing in the unanesthetized and unrestrained animal and how that might inform upon disease.

To better understand the role of NA-based glutamatergic signaling in breathing, we sought to both fully characterize the molecular profiles of the central NA system with respect to glutamate co-expression and to test the hypothesis that Vglut2-based glutamatergic release is required in respiratory control under physiological chemosensory challenges in unanesthetized and unrestrained mice. We first fully characterized the recombinase-based cumulative fate maps for Vglut1, Vglut2, and Vglut3 expression and compared those maps to their real-time expression profiles in central NA neurons by RNA in situ hybridization in adult mice. We found a novel dynamic expression pattern for Vglut2 and an entirely undescribed co-expression domain for Vglut3 in the central NA system. Second, to determine if Vglut2-based glutamatergic signaling in NA neurons is required for respiratory homeostasis, we conditionally ablated Vglut2 in all NA neurons and tested respiratory, chemosensory, and metabolic function in unrestrained and unanesthetized mice. Using the same genetic model in prior studies (Abbott et al., 2014), conditional deletion of Vglut2 in NA neurons did not significantly impact breathing under room air, hypercapnic, or hypoxic conditions. These results demonstrate, for the first time, that NA Vglut2-based glutamatergic signaling is dispensable for respiratory control, which challenges the prevalent perspective on the role of C1 and other Vglut2-expressing NA neurons in respiratory homeostasis and suggests that glutamate may not be a critical target to understand NA neuron dysfunction in respiratory diseases.

Neuron co-transmission of two or more neurotransmitters across excitatory, inhibitory, and neuro-modulatory facets is becoming an increasingly appreciated phenomenon in the central nervous system. Functional interrogation of co-transmission is essential not only to understand the distinct and cooperative roles that multiple signaling molecules may play at the synapse but also to determine the most critical targets for potential therapeutics. To our knowledge, the unopposed paradigm in the field until now has been that vesicular glutamate transporter 2 (Vglut2)-based glutamate transmission from central NA neurons is important in respiratory homeostasis. Anatomically, it has long been appreciated that central NA neurons co-express Vglut2, the major glutamate marker among three glutamate transporters (DePuy et al., 2013; Souza et al., 2022b; Stornetta et al., 2002a; Stornetta et al., 2002b; Yang et al., 2021). Also, it has been well documented that NA Vglut2 positive fibers innervate known central respiratory centers or other autonomic centers, that, when perturbed, could potentially disrupt respiratory homeostasis (Supplementary file 1). Functionally, multiple reports have suggested that Vglut2-based glutamate transmission plays a role in respiratory homeostasis (Abbott et al., 2014; Malheiros-Lima et al., 2022, 2020, 2018). It has also been suggested that, at least for C1 neurons, the apparent lack of a plasmalemmal monoamine transporter may attenuate or eliminate NA or adrenergic release from these fibers (Guyenet et al., 2013). However, as discussed below, much of the functional evidence supporting a role for Vglut2-based glutamate transmission from central NA neurons in breathing is circumstantial or of a non-physiological nature, and absent or attenuated release of adrenaline and noradrenaline has not been demonstrated. Nonetheless, the dominant perspective that NA-Vglut2 glutamate transmission plays a role in breathing has remained unchallenged. Our studies, in contrast to prior work, show that loss of Vglut2 in NA neurons does not appreciably change baseline or chemosensory breathing in unanesthetized and unrestrained mice. Additionally, our work uncovers a novel dynamic expression pattern for Vglut2 and an entirely undescribed co-expression domain for Vglut3 in central NA neurons.

Vglut2 has been shown to be co-expressed in subsets of central NA neurons, however, to our knowledge, the potential for the central NA neurons to express the other glutamate transporters Vglut1 or Vglut3 has not been reported at the anatomical level. To determine if central NA neurons express either Vglut1 or Vglut3 and to confirm the Vglut2 expression, we carried out cumulative intersectional fate mapping using Slc17a7^Cre; Dbh^p2a-Flpo; Rosa26^RC::FLTG, Slc17a6^Cre; Dbh^p2a-Flpo; Rosa26^RC::FLTG and Slc17a8^Cre; Dbh^p2a-Flpo; Rosa26^RC::FLTG compound mouse lines. As this approach maps the cumulative history of expression, we also examined acute adult expression of Slc17a7 (Vglut1), Slc17a6 (Vglut2), and Slc17a8 (Vglut3) using fluorescent RNA in situ hybridization. Our in situ results for Slc17a6 (Vglut2) agreed with earlier published outcomes (DePuy et al., 2013; Stornetta et al., 2002a; Stornetta et al., 2002b) showing as much as 80% expression in posterior NA neurons. However, there was no appreciable signal in anterior groups (A7, LC, A5, sub CD/CV). This lack of expression was in stark contrast to the cumulative fate map for Vglut2, showing as much as 75% of the anterior central NA neurons were recombined by the Vglut2-Cre over the lifetime of the animal. To further interrogate the acute activity of the Vglut2-Cre in the Locus Coeruleus in the adult mouse, we injected a Cre responsive virus in LC of Slc17a6^Cre mice and found sparse Vglut2-Cre positive NA neurons in the LC. The outcomes from the cumulative fate map and acute injections are in agreement with published results from Yang et al., 2021. Notably, our use of the Dbh^p2a-Flpo avoided expression in the parabrachial nucleus, which was a confounding variable in the Th^Flpo mouse. In addition, 28.5% of A5 neurons were shown to be Slc17a6 (Vglut2) positive in adult rats by RNA scope (Souza et al., 2022a). It is notable that both our lab and the work published by Stornetta et al., 2002a; Stornetta et al., 2002b failed to detect Slc17a6 (Vglut2) expression in anterior groups, but that apparently very low levels can be detected by more sensitive recombinase and RNA scope methods. Additional electrophysiological evidence suggests that this expression is functional (Yang et al., 2021). However, it is notable that we see nearly 80% of the LC and 85% of A5 recombined in the intersectional strategy representing lifetime expression, but our study and others find only 20% of the LC and 28.5% of A5 may be expressing Slc17a6 (Vglut2) at any given moment in adults. Thus, it suggests that Vglut2 co-expression in anterior NA groups is time dependent, though the underlying temporal dynamics of Vglut2 remain unknown. We hypothesize that this could be either a temporal restriction in expression as the animal matures or may reflect dynamic change driven by behavioral or physiological experiences, which could be tested with the use of inducible conditional strategies.

For Slc17a7 (Vglut1), neither fate map nor in situ hybridization revealed any co-expression within the central NA system. However, Slc17a8 (Vglut3) expression was found in the posterior part of NA neurons including C2/A2 and C1/A1. This study is the first to characterize this expression. The majority of this Vglut3 co-expression is restricted to the posterior part of the C2/A2 NA population. This NA region has not been heavily implicated in respiratory control nonetheless it readily lends itself to interrogation by intersectional genetic methods and in situ hybridization. Given its distal expression from anterior C1, it is less likely that Vglut3 would compensate for loss of Vglut2 in anterior C1, though this has not been ruled out. Furthermore, while Vglut3 is a marker of glutamatergic neurons, its role in neurotransmission is not wholly defined as Vglut3 is typically found in soma and dendrites (Fremeau et al., 2004).

The cumulative fate map and in situ hybridization experiments were performed in both females and males and no obvious sex difference was observed in the expression pattern of Vglut1, Vglut2, or Vglut3. However, only three mice were characterized in each dataset, thus, larger sample sizes may capture more subtle outcomes for potential sex differences.

Based on the Vglut2 co-expression in NA neurons and their projections to multiple brain regions important in respiration, several studies suggest that glutamate in NA populations is important in breathing control. However, the evidence those studies provided is circumstantial, indirect, or limited due to experimental caveats or technical limitations. Abbott et al., 2014, using exactly the same mouse model as this study, showed that conditionally knocking out Vglut2 in the whole central NA system did not significantly change respiratory rate under room air, which is consistent with our findings here. Our results differ in that they reported removing Vglut2 from central NA neurons attenuated an increase in respiratory rate resulting from unilateral C1 optogenetic stimulation. However, while the optogenetic stimulation of C1 neurons did drive a Vglut2-dependent increase in respiratory rate, it is not clear if the resulting change in breathing reflects a native feature of the network that might be engaged in chemosensory responses or other aspects of breathing. It remains possible that strong unilateral optogenetic stimulation (up to 20 Hz) of a small, isolated population drives a Vglut2-dependent, but ectopic, function that is not typically engaged in the normal operation of the breathing network. Such ectopic outcomes could come from several potential, non-exclusive mechanisms. First, unilateral stimulation could drive a network hysteresis or dysregulation similar to a focal injury that is not a typical biological feature (Ducros et al., 2003). This point is well made in Abbott et al., 2013 in their discussion of C1 optogenetic stimulation where they state, ‘resulting cardiorespiratory response pattern should not be considered strictly “physiological,” because a physiological response is never initiated by selective activation of a single cluster of CNS neurons and the various subsets of C1 neurons are presumably never recruited en bloc under any physiological condition’. Second, strong stimulation could result in overwhelming synaptic mechanisms (i.e., glial uptake) resulting in glutamate spillover and unintended cross talk to affect extra-synaptic neurons proximal to targeted NA fibers. Activity-dependent spillover transmission has been documented elsewhere in the nervous system (Henneberger et al., 2020; Hülsmann et al., 2000). Third, the outcomes could be secondary to a different autonomic or behavioral function requiring NA-derived glutamatergic signaling involving metabolism or circulation (DePuy et al., 2013; Yang et al., 2021). Additionally, respiratory parameters except for respiratory rate (V_f), such as tidal volume (V_T) and minute ventilation (V_E) were not reported, making comprehensive comparison difficult.

More circumstantially, Malheiros-Lima et al., 2020 suggested C1 neurons potentially release glutamate at the pFRG site to regulate active expiration under hypoxia in anesthetized rats by providing three indirect lines of evidence: (1) Vglut2-expressing C1 neurons project to the pFRG region; (2) Increased abdominal expiratory nerve activity (Abd_EMG) was blunted after blockade of ionotropic glutamatergic receptors at the pFRG site under anesthesia using cytotoxic potassium cyanide (KCN)-mediated hypoxia; and (3) Depletion of C1 neurons eliminated the increased Abd_EMG elicited by hypoxia. However, (1) the glutamatergic signaling targeting the pFRG region is not necessarily from C1 NA neurons since glutamatergic neurons from other regions also project to the pFRG site (Yang and Feldman, 2018). Thus, it is possible that the glutamatergic signaling that is required for hypoxic response is derived from other glutamatergic neurons such as the preBötzinger complex and the RTN itself. Furthermore, (2) C1 neuron depletion knocks out all the signaling modalities in the C1 population including both noradrenaline and glutamate. It is not clear which signaling drives the hypoxic response. Finally, (3) KCN injection mimics a hypoxic challenge by activating peripheral chemoreceptors, but the physiological responses differ from those seen during environmental hypoxia exposure. Thus, the abdominal activity changes due to KCN injection may not be recaptured under physiological hypoxic challenge.

Similarly, Malheiros-Lima et al., 2022 and Malheiros-Lima et al., 2018 showed that Vglut2-expressing C1 neurons project to both the NA A5 region and the preBötzinger complex. The blockade of ionotropic glutamatergic receptors at the A5 region or preBötzinger complex reduced the increase in phrenic nerve activity and the breathing frequency caused by optogenetic stimulation of C1 cells in an anesthetized preparation. Together these results suggest that Vglut2-expressing C1 neurons communicate with A5 or preBötzinger complex neurons by releasing glutamate in turn to regulate phrenic nerve activity or breathing frequency. Again, these two studies showed that C1 neurons are important to regulate phrenic nerve activity or breathing frequency, however, it is not necessarily through a direct C1–A5 or C1–preBötzinger complex glutamatergic pathway, whereas an indirect multi-synaptic pathway originating with C1 noradrenaline and ending with glutamate transmission from an intermediate to A5 or preBötzinger complex cannot be ruled out. Importantly, in all four studies noted here, respiratory measurements were limited or proxies of breathing under anesthesia were used. The role of NA-Vglut2 signaling was not reported in the context of an unanesthetized, unrestrained animal under normoxic, hypoxic, or hypercapnic breathing in these previous studies.

Thus, the limitations and indirect lines of the evidence in these studies raised the question as to whether or not glutamatergic signaling in central NA neurons is required or necessary to modulate respiratory homeostasis under more physiologically relevant circumstances and if NA-derived glutamate is an important mechanism to understand the pathophysiology of NA neurons in respiratory diseases. The goal of our study was to test the requirement of NA-based glutamatergic signaling in breathing homeostasis in the unanesthetized and unrestrained animal under conditions that would engage the whole respiratory control network rather than a singular component that may drive hysteresis or artifactual outcomes. Our in vivo breathing data under room air, hypoxic, and multiple hypercapnic conditions failed to show the requirement of NA-derived Vglut2 in normal breathing and respiratory chemoreflexes directly. For the dynamic patterns of breathing, we measured the SD1 and SD2 of eight parameters under each gas condition. We found no consistent change across multiple hypercapnic challenges or hypoxia. We did find that under severe hypercapnic challenge (10% CO₂), NA-derived Vglut2 removal resulted in an increase in the SD1 of breath cycle duration and respiratory rate, which was not observed under 5% and 7% CO₂ conditions. Under hypoxia (10% O₂), Dbh-Cre; Vglut2 cKO mice only showed an increase in the SD2 of inspiratory flow rate and minute ventilation during the first 5 min of 10% O₂ exposure. These findings may suggest that Vglut2-based glutamatergic signaling in central NA neurons may play a role in modulating breathing regularity under high CO₂ challenge and hypoxia. However, the phenotypes were of a small magnitude and not consistent across challenges, and not at all seen under homeostatic breathing.

To ensure a rigorous and robust conclusion, we included several extra precautions and additional measures in our experimental design and analysis. First, we use exactly the same mouse model, DBH-Cre; Vglut2 cKO, as Abbott et al., 2014 used, and confirmed, by a second method (fluorescent RNA in situ hybridization) that Vglut2 expression was indeed abrogated in the whole central NA system. Our results are in strong agreement with DePuy et al., 2013 that recombination is efficient. Notably, we assayed for expression at the cell body, rather than the fibers and see no singular cell body that is scored positive. Second, we measured the breathing of unanesthetized, unrestrained, and habituated mice under physiological challenges including normoxia, hypercapnia, and hypoxia. Third, to visualize breathing function comprehensively, the metabolic parameter and multiple respiratory parameters (both the steady state and the dynamic patterns) were measured and reported in absolute values including oxygen consumption, respiratory rate, tidal volume, minute ventilation, overall respiratory output (minute ventilation normalized to oxygen consumption), inspiratory duration, expiratory duration, breath cycle duration, inspiratory flow rate, and expiratory flow rate. Fourth, our experimental design was overpowered (i.e., n = 16–21 vs. 5–13 needed for power based on power analysis and n = 7–8 reported in other manuscripts). Each respiratory/metabolic parameter for each physiological condition including room air, hypercapnia, and hypoxia was derived by quantifying the entire respiratory trace and analyzed between mutant and sibling controls by using a linear mixed-effects regression model with animal type (experimental vs. control) as fixed effects, animal ID as a random effect, and sex as an experimental covariate (for which we did not find a significant effect) (Lusk et al., 2023a).

Despite our experimental design and the extensive nature of our measurements, there remain several possibilities or considerations in the interpretation of our data. The first possibility is Vglut3 in posterior CA domain (first characterized in this study) compensates for the effect of the loss of Vglut2 in NA neurons in breathing. However, we argue that this is unlikely because (1) Our model is the same used in the other study where a Vglut2-dependent effect was seen with optogenetic stimulation. (2) Vglut3 is expressed in the posterior C2/A2 NA neurons which are anatomically distant from anterior C1 and the LC (the two most likely NA candidates with Vglut2 co-expression to impact breathing). Also, posterior C2/A2 has not been heavily implicated in breathing regulation. Future work will need to further investigate the role of Vglut3 in posterior CA in respiratory control in order to test this possibility. The second possibility is that pre- or post-natal developmental compensation corrects for the loss of NA-derived glutamate. Again, we argue that is unlikely, as (1) we are using the same adult model that provided the most direct evidence and first functionally demonstrated a potential role for C1-derived glutamate in breathing; (2) Abbott et al., 2014 highlight that C1 NA neurons showed no obvious abnormalities in number, morphology, and projection patterns after knocking out Vglut2; and (3) we have examined the requirement of NA-expressed Vglut2 in P7 neonate mice in the autoresuscitation reflex and saw no differences (data not shown). However, it is still possible that developmental compensation occurs before P7, which is something that could be better tested by using the Dbh-CreERT2 (Stubbusch et al., 2011) to more acutely remove Vglut2 expression (though this leaves a window of 2–3 weeks for compensation to occur). Third, as we only address the loss of NA-Vglut2-based signaling across the entire NA system, it remains a formal possibility that this ultimately results in the removal of Vglut2-dependent signaling from two counter balancing regions of the NA system and are therefore left with null results whereas removal from anterior C1 alone would show a requirement. To test this possibility, it would require an intersectional conditional knockout/loss of function approach, something that has not yet been shown to be efficient and effective and would be beyond the scope of these studies. Fourth, it is possible that another neurotransmitter/neuropeptide within NA neurons might be released in higher amounts in Dbh-Cre; Vglut2 cKO mice to compensate for the deficiency of glutamate in breathing. Loss of Vglut2 could reduce dopamine release in subsets of dopaminergic neurons (Alsiö et al., 2011; Fortin et al., 2012; Hnasko et al., 2010). Thus, it remains possible that loss of Vglut2 affects dopamine loading into the vesicles and in turn affecting noradrenaline release as dopamine beta hydroxylase (DBH) synthesizes noradrenaline from dopamine inside the vesicles (Weinshenker, 2007). Changes in noradrenaline release in Vglut2 negative NA neurons could be further examined with fast-scan cyclic voltammetry or microdialysis. Neuropeptide Y (NPY) and galanin have been shown to co-exist in LC NA neurons and are involved in regulating energy metabolism, stress, or anxiety (Ruohonen et al., 2012; Tasan et al., 2010; Weinshenker and Holmes, 2016). In our studies, we account for potential metabolic changes that may underlie or be coordinate with changes in breathing. However, we did not test for potential changes in blood pressure or other autonomic functions as well as affective state that may, in some obscure way, compensate for changes in breathing. Further interrogation of NPY or galanin signaling across NA neurons and potential compensatory effects in breathing through changes in metabolism or other autonomic function under stress or anxiety may yield notable insights. Lastly, our results are loss of function in nature. We do not test sufficiency or gain of function and cannot fully rule out a role for NA-Vglut2-based glutamatergic signaling in the control of breathing.

From a translational perspective, our data question whether or not glutamatergic signaling in NA neurons is likely to be a key mechanism and therefore a therapeutic target for breathing disorders, such as Rett Syndrome and SIDS. Mecp2-deficient mice (a mouse model of Rett Syndrome that phenocopies many human symptoms) showed both a deficiency of NA populations (reduced number of NA neurons in C2/A2 and C1/A1 group) and highly variable respiratory rhythm at around 4–5 weeks of age (Roux et al., 2007; Viemari et al., 2005). 80% of Rett Syndrome patients experience breathing issues, such as unstable breathing, episodes of hyperventilation, and breath holds, throughout their lifespan (Ramirez et al., 2020). SIDS decedents show NA abnormalities and are hypothesized to ultimately succumb from a failure in cardiorespiratory autoresuscitation (Chigr et al., 1989; Garcia et al., 2013; Kopp et al., 1993; Mansouri et al., 2001; Ozawa et al., 2003; Takashima and Becker, 1991). However, Dbh-Cre; Vglut2 cKO mice have normal baseline and chemosensory respiratory parameters as adults and neonate mice show normal autoresuscitation indicating that perturbed NA-based glutamatergic signaling may not be a key driver in these or other related respiratory pathophysiologies.

In conclusion, our studies show that Vglut2 has a dynamic and extensive expression profile across the central NA system. We were able to characterize a novel Vglut3-expressing NA population in the posterior C2/A2 nuclei. Despite prior studies providing indirect and circumstantial evidence that NA-based glutamatergic signaling may play a role in control of breathing, our conditional loss of function studies in adult unanesthetized and unrestrained mice failed to consistently and significantly change room air breathing, the hypercapnic ventilatory reflex, and the hypoxic ventilatory reflex. These outcomes offer a contrasting perspective from the current field view and provides further insight into the potential role of NA-glutamate transmission in the control of breathing and NA neuron dysfunction in respiratory disorders.

Source data files have been provided for Figures 1, 2, 3, and their supplements. Raw plethysmography data for Figures 4, 5, 6, 7, and their supplements is posted on Zenodo (https://doi.org/10.5281/zenodo.11557289; https://doi.org/10.5281/zenodo.11557468; https://doi.org/10.5281/zenodo.11557554; https://doi.org/10.5281/zenodo.11557569). Breathe Easy software code used for plethysmography data analysis is posted on Github: https://github.com/MolecularNeurobiology/Breathe_Easy (Lusk et al., 2023b).

1. 1. Chang Y
   2. Ray R

   (2024) Zenodo

   Raw plethysmography data for Figure 4_5% CO2 protocol.

   https://doi.org/10.5281/zenodo.11557289
2. 1. Chang Y
   2. Ray R

   (2024) Zenodo

   Raw plethysmography data for Figure 5_7% CO2 protocol.

   https://doi.org/10.5281/zenodo.11557468
3. 1. Chang Y
   2. Ray R

   (2024) Zenodo

   Raw plethysmography data for Figure 6_10% CO2 protocol.

   https://doi.org/10.5281/zenodo.11557554
4. 1. Chang Y
   2. Ray R

   (2024) Zenodo

   Raw plethysmography data for Figure 7_10% O2 protocol.

   https://doi.org/10.5281/zenodo.11557569

1. 1. Abbott SBG
   2. DePuy SD
   3. Nguyen T
   4. Coates MB
   5. Stornetta RL
   6. Guyenet PG

   (2013) Selective optogenetic activation of rostral ventrolateral medullary catecholaminergic neurons produces cardiorespiratory stimulation in conscious mice

   The Journal of Neuroscience 33:3164–3177.

   https://doi.org/10.1523/JNEUROSCI.1046-12.2013

   • PubMed
   • Google Scholar
2. 1. Abbott SBG
   2. Holloway BB
   3. Viar KE
   4. Guyenet PG

   (2014) Vesicular glutamate transporter 2 is required for the respiratory and parasympathetic activation produced by optogenetic stimulation of catecholaminergic neurons in the rostral ventrolateral medulla of mice in vivo

   The European Journal of Neuroscience 39:98–106.

   https://doi.org/10.1111/ejn.12421

   • PubMed
   • Google Scholar
3. 1. Alsiö J
   2. Nordenankar K
   3. Arvidsson E
   4. Birgner C
   5. Mahmoudi S
   6. Halbout B
   7. Smith C
   8. Fortin GM
   9. Olson L
   10. Descarries L
   11. Trudeau LÉ
   12. Kullander K
   13. Lévesque D
   14. Wallén-Mackenzie A

   (2011) Enhanced sucrose and cocaine self-administration and cue-induced drug seeking after loss of VGLUT2 in midbrain dopamine neurons in mice

   The Journal of Neuroscience 31:12593–12603.

   https://doi.org/10.1523/JNEUROSCI.2397-11.2011

   • PubMed
   • Google Scholar
4. 1. Beltrán-Castillo S
   2. Olivares MJ
   3. Contreras RA
   4. Zúñiga G
   5. Llona I
   6. von Bernhardi R
   7. Eugenín JL

   (2017) D-serine released by astrocytes in brainstem regulates breathing response to CO₂ levels

   Nature Communications 8:838.

   https://doi.org/10.1038/s41467-017-00960-3

   • PubMed
   • Google Scholar
5. 1. Chigr F
   2. Najimi M
   3. Jordan D
   4. Denoroy L
   5. Pearson J
   6. Tommasi M
   7. Gilly R
   8. Kopp N

   (1989)

   Immunohistochemical absence of adrenergic neurons in the dorsal part of the solitary tract nucleus in sudden infant death

   Comptes Rendus de l’Academie Des Sciences. Serie III, Sciences de La Vie 309:543–549.

   • PubMed
   • Google Scholar
6. 1. Comer AM
   2. Qi J
   3. Christie DL
   4. Gibbons HM
   5. Lipski J

   (1998) Noradrenaline transporter expression in the pons and medulla oblongata of the rat: localisation to noradrenergic and some C1 adrenergic neurones

   Brain Research. Molecular Brain Research 62:65–76.

   https://doi.org/10.1016/s0169-328x(98)00241-1

   • PubMed
   • Google Scholar
7. 1. Del Negro CA
   2. Funk GD
   3. Feldman JL

   (2018) Breathing matters

   Nature Reviews. Neuroscience 19:351–367.

   https://doi.org/10.1038/s41583-018-0003-6

   • PubMed
   • Google Scholar
8. 1. DePuy SD
   2. Stornetta RL
   3. Bochorishvili G
   4. Deisseroth K
   5. Witten I
   6. Coates M
   7. Guyenet PG

   (2013) Glutamatergic neurotransmission between the C1 neurons and the parasympathetic preganglionic neurons of the dorsal motor nucleus of the vagus

   The Journal of Neuroscience 33:1486–1497.

   https://doi.org/10.1523/JNEUROSCI.4269-12.2013

   • PubMed
   • Google Scholar
9. 1. Dick TE
   2. Dutschmann M
   3. Feldman JL
   4. Fong AY
   5. Hülsmann S
   6. Morris KM
   7. Ramirez JM
   8. Smith JC
   9. Respiratory Neurobiology Consortium

   (2018) Facts and challenges in respiratory neurobiology

   Respiratory Physiology & Neurobiology 258:104–107.

   https://doi.org/10.1016/j.resp.2015.01.014

   • PubMed
   • Google Scholar
10. 1. Ducros L
    2. Vahedi K
    3. Similowski T
    4. Bousser MG
    5. Payen D

    (2003) Uncontrollable high-frequency tachypnea in a case of unilateral medial medullary infarct

    Intensive Care Medicine 29:841–844.

    https://doi.org/10.1007/s00134-003-1658-6

    • PubMed
    • Google Scholar
11. 1. Feldman JL
    2. Del Negro CA
    3. Gray PA

    (2013) Understanding the rhythm of breathing: so near, yet so far

    Annual Review of Physiology 75:423–452.

    https://doi.org/10.1146/annurev-physiol-040510-130049

    • PubMed
    • Google Scholar
12. 1. Ferreira CB
    2. Silva TM
    3. Silva PE
    4. Castro CL
    5. Czeisler C
    6. Otero JJ
    7. Takakura AC
    8. Moreira TS

    (2022) Phox2b mutation mediated by Atoh1 expression impaired respiratory rhythm and ventilatory responses to hypoxia and hypercapnia

    eLife 11:e73130.

    https://doi.org/10.7554/eLife.73130

    • PubMed
    • Google Scholar
13. 1. Fortin GM
    2. Bourque MJ
    3. Mendez JA
    4. Leo D
    5. Nordenankar K
    6. Birgner C
    7. Arvidsson E
    8. Rymar VV
    9. Bérubé-Carrière N
    10. Claveau AM
    11. Descarries L
    12. Sadikot AF
    13. Wallén-Mackenzie Å
    14. Trudeau LÉ

    (2012) Glutamate corelease promotes growth and survival of midbrain dopamine neurons

    The Journal of Neuroscience 32:17477–17491.

    https://doi.org/10.1523/JNEUROSCI.1939-12.2012

    • PubMed
    • Google Scholar
14. 1. Fremeau RT
    2. Voglmaier S
    3. Seal RP
    4. Edwards RH

    (2004) VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate

    Trends in Neurosciences 27:98–103.

    https://doi.org/10.1016/j.tins.2003.11.005

    • PubMed
    • Google Scholar
15. 1. Garcia AJ
    2. Koschnitzky JE
    3. Ramirez JM

    (2013) The physiological determinants of sudden infant death syndrome

    Respiratory Physiology & Neurobiology 189:288–300.

    https://doi.org/10.1016/j.resp.2013.05.032

    • PubMed
    • Google Scholar
16. 1. Gauda EB
    2. Cristofalo E
    3. Nunez J

    (2007) Peripheral arterial chemoreceptors and sudden infant death syndrome

    Respiratory Physiology & Neurobiology 157:162–170.

    https://doi.org/10.1016/j.resp.2007.02.016

    • PubMed
    • Google Scholar
17. 1. Guyenet PG
    2. Stornetta RL
    3. Bochorishvili G
    4. Depuy SD
    5. Burke PGR
    6. Abbott SBG

    (2013) C1 neurons: the body’s EMTs

    American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 305:R187–R204.

    https://doi.org/10.1152/ajpregu.00054.2013

    • PubMed
    • Google Scholar
18. 1. Haxhiu MA
    2. Yung K
    3. Erokwu B
    4. Cherniack NS

    (1996) CO2-induced c-fos expression in the CNS catecholaminergic neurons

    Respiration Physiology 105:35–45.

    https://doi.org/10.1016/0034-5687(96)00034-5

    • PubMed
    • Google Scholar
19. 1. Henneberger C
    2. Bard L
    3. Panatier A
    4. Reynolds JP
    5. Kopach O
    6. Medvedev NI
    7. Minge D
    8. Herde MK
    9. Anders S
    10. Kraev I
    11. Heller JP
    12. Rama S
    13. Zheng K
    14. Jensen TP
    15. Sanchez-Romero I
    16. Jackson CJ
    17. Janovjak H
    18. Ottersen OP
    19. Nagelhus EA
    20. Oliet SHR
    21. Stewart MG
    22. Nägerl UV
    23. Rusakov DA

    (2020) LTP induction boosts glutamate spillover by driving withdrawal of perisynaptic astroglia

    Neuron 108:919–936.

    https://doi.org/10.1016/j.neuron.2020.08.030

    • PubMed
    • Google Scholar
20. 1. Hnasko TS
    2. Chuhma N
    3. Zhang H
    4. Goh GY
    5. Sulzer D
    6. Palmiter RD
    7. Rayport S
    8. Edwards RH

    (2010) Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo

    Neuron 65:643–656.

    https://doi.org/10.1016/j.neuron.2010.02.012

    • PubMed
    • Google Scholar
21. 1. Hülsmann S
    2. Oku Y
    3. Zhang W
    4. Richter DW

    (2000) Metabotropic glutamate receptors and blockade of glial Krebs cycle depress glycinergic synaptic currents of mouse hypoglossal motoneurons

    The European Journal of Neuroscience 12:239–246.

    https://doi.org/10.1046/j.1460-9568.2000.00902.x

    • PubMed
    • Google Scholar
22. 1. Kopp N
    2. Chigr F
    3. Denoroy L
    4. Gilly R
    5. Jordan D

    (1993) Absence of adrenergic neurons in nucleus tractus solitarius in sudden infant death syndrome

    Neuropediatrics 24:25–29.

    https://doi.org/10.1055/s-2008-1071508

    • PubMed
    • Google Scholar
23. 1. Lorang D
    2. Amara SG
    3. Simerly RB

    (1994) Cell-type-specific expression of catecholamine transporters in the rat brain

    The Journal of Neuroscience 14:4903–4914.

    https://doi.org/10.1523/JNEUROSCI.14-08-04903.1994

    • PubMed
    • Google Scholar
24. 1. Lusk S
    2. Ward CS
    3. Chang A
    4. Twitchell-Heyne A
    5. Fattig S
    6. Allen G
    7. Jankowsky JL
    8. Ray RS

    (2023a) An automated respiratory data pipeline for waveform characteristic analysis

    The Journal of Physiology 601:4767–4806.

    https://doi.org/10.1113/JP284363

    • PubMed
    • Google Scholar
25. Software

    1. Lusk S
    2. Chang A
    3. Twitchell-Heyne A
    4. Fattig S
    5. Ward CS
    6. Ray R

    (2023b) Breathe_Easy, version 9136289

    GitHub.

    https://github.com/MolecularNeurobiology/Breathe_Easy
26. 1. Malheiros-Lima MR
    2. Totola LT
    3. Lana MVG
    4. Strauss BE
    5. Takakura AC
    6. Moreira TS

    (2018) Breathing responses produced by optogenetic stimulation of adrenergic C1 neurons are dependent on the connection with preBötzinger complex in rats

    Pflugers Archiv 470:1659–1672.

    https://doi.org/10.1007/s00424-018-2186-0

    • PubMed
    • Google Scholar
27. 1. Malheiros-Lima MR
    2. Silva JN
    3. Souza FC
    4. Takakura AC
    5. Moreira TS

    (2020) C1 neurons are part of the circuitry that recruits active expiration in response to the activation of peripheral chemoreceptors

    eLife 9:e52572.

    https://doi.org/10.7554/eLife.52572

    • PubMed
    • Google Scholar
28. 1. Malheiros-Lima MR
    2. Silva TM
    3. Takakura AC
    4. Moreira TS

    (2022) A5 noradrenergic-projecting C1 neurons activate sympathetic and breathing outputs in anaesthetized rats

    Experimental Physiology 107:147–160.

    https://doi.org/10.1113/EP089691

    • PubMed
    • Google Scholar
29. 1. Mansouri J
    2. Panigrahy A
    3. Filiano JJ
    4. Sleeper LA
    5. St John WM
    6. Kinney HC

    (2001) Alpha2 receptor binding in the medulla oblongata in the sudden infant death syndrome

    Journal of Neuropathology and Experimental Neurology 60:141–146.

    https://doi.org/10.1093/jnen/60.2.141

    • PubMed
    • Google Scholar
30. 1. Martinez VK
    2. Saldana-Morales F
    3. Sun JJ
    4. Zhu PJ
    5. Costa-Mattioli M
    6. Ray RS

    (2019) Off-target effects of clozapine-N-oxide on the chemosensory reflex are masked by high stress levels

    Frontiers in Physiology 10:521.

    https://doi.org/10.3389/fphys.2019.00521

    • PubMed
    • Google Scholar
31. 1. Ozawa Y
    2. Takashima S
    3. Tada H

    (2003) Alpha2-adrenergic receptor subtype alterations in the brainstem in the sudden infant death syndrome

    Early Human Development 75 Suppl:S129–S138.

    https://doi.org/10.1016/j.earlhumdev.2003.08.016

    • PubMed
    • Google Scholar
32. 1. Ramirez JM
    2. Karlen-Amarante M
    3. Wang JDJ
    4. Bush NE
    5. Carroll MS
    6. Weese-Mayer DE
    7. Huff A

    (2020) The pathophysiology of rett syndrome with a focus on breathing dysfunctions

    Physiology 35:375–390.

    https://doi.org/10.1152/physiol.00008.2020

    • PubMed
    • Google Scholar
33. 1. Ray RS
    2. Corcoran AE
    3. Brust RD
    4. Kim JC
    5. Richerson GB
    6. Nattie E
    7. Dymecki SM

    (2011) Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition

    Science 333:637–642.

    https://doi.org/10.1126/science.1205295

    • PubMed
    • Google Scholar
34. 1. Robertson SD
    2. Plummer NW
    3. de Marchena J
    4. Jensen P

    (2013) Developmental origins of central norepinephrine neuron diversity

    Nature Neuroscience 16:1016–1023.

    https://doi.org/10.1038/nn.3458

    • PubMed
    • Google Scholar
35. 1. Roux JC
    2. Dura E
    3. Moncla A
    4. Mancini J
    5. Villard L

    (2007) Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome

    The European Journal of Neuroscience 25:1915–1922.

    https://doi.org/10.1111/j.1460-9568.2007.05466.x

    • PubMed
    • Google Scholar
36. 1. Ruohonen ST
    2. Pesonen U
    3. Savontaus E

    (2012) Neuropeptide Y in the noradrenergic neurons induces the development of cardiometabolic diseases in a transgenic mouse model

    Indian Journal of Endocrinology and Metabolism 16:S569–S576.

    https://doi.org/10.4103/2230-8210.105574

    • PubMed
    • Google Scholar
37. 1. Souza G
    2. Stornetta RL
    3. Stornetta DS
    4. Guyenet PG
    5. Abbott SBG

    (2022a) Adrenergic C1 neurons monitor arterial blood pressure and determine the sympathetic response to hemorrhage

    Cell Reports 38:110480.

    https://doi.org/10.1016/j.celrep.2022.110480

    • PubMed
    • Google Scholar
38. 1. Souza G
    2. Stornetta DS
    3. Vitali AJ
    4. Wildner H
    5. Zeilhofer HU
    6. Campbell JN
    7. Abbott SBG

    (2022b) Chemogenetic activation of noradrenergic A5 neurons increases blood pressure and visceral sympathetic activity in adult rats

    American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 323:R512–R531.

    https://doi.org/10.1152/ajpregu.00119.2022

    • PubMed
    • Google Scholar
39. 1. Stornetta RL
    2. Sevigny CP
    3. Guyenet PG

    (2002a) Vesicular glutamate transporter DNPI/VGLUT2 mRNA is present in C1 and several other groups of brainstem catecholaminergic neurons

    The Journal of Comparative Neurology 444:191–206.

    https://doi.org/10.1002/cne.10141

    • PubMed
    • Google Scholar
40. 1. Stornetta RL
    2. Sevigny CP
    3. Schreihofer AM
    4. Rosin DL
    5. Guyenet PG

    (2002b) Vesicular glutamate transporter DNPI/VGLUT2 is expressed by both C1 adrenergic and nonaminergic presympathetic vasomotor neurons of the rat medulla

    The Journal of Comparative Neurology 444:207–220.

    https://doi.org/10.1002/cne.10142

    • PubMed
    • Google Scholar
41. 1. Stubbusch J
    2. Majdazari A
    3. Schmidt M
    4. Schütz G
    5. Deller T
    6. Rohrer H

    (2011) Generation of the tamoxifen-inducible DBH-Cre transgenic mouse line DBH-CT

    Genesis 49:935–941.

    https://doi.org/10.1002/dvg.20773

    • PubMed
    • Google Scholar
42. 1. Sun JJ
    2. Ray R

    (2016) Generation of two noradrenergic-specific dopamine-beta-hydroxylase-FLPo knock-in mice using CRISPR/Cas9-mediated targeting in embryonic stem cells

    PLOS ONE 11:e0159474.

    https://doi.org/10.1371/journal.pone.0159474

    • PubMed
    • Google Scholar
43. 1. Takashima S
    2. Becker LE

    (1991) Delayed dendritic development of catecholaminergic neurons in the ventrolateral medulla of children who died of sudden infant death syndrome

    Neuropediatrics 22:97–99.

    https://doi.org/10.1055/s-2008-1071424

    • PubMed
    • Google Scholar
44. 1. Tasan RO
    2. Nguyen NK
    3. Weger S
    4. Sartori SB
    5. Singewald N
    6. Heilbronn R
    7. Herzog H
    8. Sperk G

    (2010) The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression

    The Journal of Neuroscience 30:6282–6290.

    https://doi.org/10.1523/JNEUROSCI.0430-10.2010

    • PubMed
    • Google Scholar
45. 1. Tong Q
    2. Ye C
    3. McCrimmon RJ
    4. Dhillon H
    5. Choi B
    6. Kramer MD
    7. Yu J
    8. Yang Z
    9. Christiansen LM
    10. Lee CE
    11. Choi CS
    12. Zigman JM
    13. Shulman GI
    14. Sherwin RS
    15. Elmquist JK
    16. Lowell BB

    (2007) Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia

    Cell Metabolism 5:383–393.

    https://doi.org/10.1016/j.cmet.2007.04.001

    • PubMed
    • Google Scholar
46. 1. Viemari JC
    2. Roux JC
    3. Tryba AK
    4. Saywell V
    5. Burnet H
    6. Peña F
    7. Zanella S
    8. Bévengut M
    9. Barthelemy-Requin M
    10. Herzing LBK
    11. Moncla A
    12. Mancini J
    13. Ramirez JM
    14. Villard L
    15. Hilaire G

    (2005) Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice

    The Journal of Neuroscience 25:11521–11530.

    https://doi.org/10.1523/JNEUROSCI.4373-05.2005

    • PubMed
    • Google Scholar
47. 1. Viemari JC

    (2008) Noradrenergic modulation of the respiratory neural network

    Respiratory Physiology & Neurobiology 164:123–130.

    https://doi.org/10.1016/j.resp.2008.06.016

    • PubMed
    • Google Scholar
48. Book

    1. Weinshenker D

    (2007) Dopamine Beta-HydroxylaseXPharm: The Comprehensive Pharmacology Reference

    Elsevier.

    https://doi.org/10.1016/B978-008055232-3.60505-7

    • Google Scholar
49. 1. Weinshenker D
    2. Holmes PV

    (2016) Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin

    Brain Research 1641:320–337.

    https://doi.org/10.1016/j.brainres.2015.11.025

    • PubMed
    • Google Scholar
50. 1. Yang CF
    2. Feldman JL

    (2018) Efferent projections of excitatory and inhibitory preBötzinger Complex neurons

    The Journal of Comparative Neurology 526:1389–1402.

    https://doi.org/10.1002/cne.24415

    • PubMed
    • Google Scholar
51. 1. Yang B
    2. Sanches-Padilla J
    3. Kondapalli J
    4. Morison SL
    5. Delpire E
    6. Awatramani R
    7. Surmeier DJ

    (2021) Locus coeruleus anchors a trisynaptic circuit controlling fear-induced suppression of feeding

    Neuron 109:823–838.

    https://doi.org/10.1016/j.neuron.2020.12.023

    • PubMed
    • Google Scholar
52. 1. Yaylaoglu MB
    2. Titmus A
    3. Visel A
    4. Alvarez-Bolado G
    5. Thaller C
    6. Eichele G

    (2005) Comprehensive expression atlas of fibroblast growth factors and their receptors generated by a novel robotic in situ hybridization platform

    Developmental Dynamics 234:371–386.

    https://doi.org/10.1002/dvdy.20441

    • PubMed
    • Google Scholar

Author details

1. Yuan Chang

   1. Department of Neuroscience, Baylor College of Medicine, Houston, United States
   2. Department of Integrative Physiology, Baylor College of Medicine, Houston, United States

   Contribution

   Writing – original draft, Writing – review and editing, Designed and completed immunofluorescence staining, imaging, and plethysmography experiments, Analyzed the data

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-9837-2897

2. Savannah Lusk

   Department of Neuroscience, Baylor College of Medicine, Houston, United States

   Contribution

   Writing – review and editing, Completed the viral injection experiments

   Competing interests

   No competing interests declared

3. Andersen Chang

   Department of Neuroscience, Baylor College of Medicine, Houston, United States

   Contribution

   Software, Writing – review and editing, Helped analyze the data

   Competing interests

   No competing interests declared

4. Christopher S Ward

   Department of Integrative Physiology, Baylor College of Medicine, Houston, United States

   Contribution

   Software, Writing – review and editing, Helped analyze the data

   Competing interests

   No competing interests declared

5. Russell S Ray

   1. Department of Neuroscience, Baylor College of Medicine, Houston, United States
   2. Department of Integrative Physiology, Baylor College of Medicine, Houston, United States
   3. McNair Medical Institute, Houston, United States

   Contribution

   Resources, Funding acquisition, Writing – review and editing, Conceptualized and designed the study, Analyzed the data, Helped write the initial manuscript

   For correspondence

   Russell.Ray@bcm.edu

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-9610-2703

• 798

  views

• 49

  downloads

• 0

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.